Clonal hematopoiesis: mechanisms driving dominance of stem cell clones

GA Challen, MA Goodell - Blood, The Journal of the American …, 2020 - ashpublications.org
The discovery of clonal hematopoiesis (CH) in older individuals has changed the way
hematologists and stem cell biologists view aging. Somatic mutations accumulate in stem …

Somatic mutations in “benign” disease

S Mustjoki, NS Young - New England Journal of Medicine, 2021 - Mass Medical Soc
Somatic Mutations in “Benign” Disease DNA mutations occur in nearly every tissue
throughout the human life span and accumulate at various rates in different tissues …

Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease

C Vlasschaert, AJM McNaughton… - Journal of the …, 2022 - journals.lww.com
Background Clonal hematopoiesis of indeterminate potential (CHIP) is an inflammatory
premalignant disorder resulting from acquired genetic mutations in hematopoietic stem cells …

The impact of inflammation-induced tumor plasticity during myeloid transformation

A Yeaton, G Cayanan, S Loghavi, I Dolgalev… - Cancer discovery, 2022 - AACR
Clonal hematopoiesis (CH) is an aging-associated condition characterized by the clonal
outgrowth of mutated preleukemic cells. Individuals with CH are at an increased risk of …

Clonal hematopoiesis and risk of incident lung cancer

R Tian, B Wiley, J Liu, X Zong, B Truong… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To prospectively examine the association between clonal hematopoiesis (CH)
and subsequent risk of lung cancer. METHODS Among 200,629 UK Biobank (UKBB) …

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification

H Pasquer, R Daltro de Oliveira, L Vasseur… - Leukemia, 2024 - nature.com
Current recommended risk scores to predict thrombotic events associated with
myeloproliferative neoplasms (MPN) do not discriminate between arterial and venous …

CHIP happens: clonal hematopoiesis of indeterminate potential and its relationship to solid tumors

SC Reed, S Croessmann, BH Park - Clinical Cancer Research, 2023 - AACR
Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by the expansion of
hematopoietic cells harboring leukemia-associated somatic mutations in otherwise healthy …

Clonal hematopoiesis: from mechanisms to clinical intervention

T Köhnke, R Majeti - Cancer discovery, 2021 - AACR
Our knowledge of how clonal hematopoiesis relates to diverse health conditions has grown
vastly over the past years, touching upon many specialties beyond cancer medicine. Given …

Clonal hematopoiesis and its emerging effects on cellular therapies

M von Bonin, HK Jambor, R Teipel, F Stölzel, C Thiede… - Leukemia, 2021 - nature.com
The accumulation of somatic mutations in hematopoietic stem cells during aging, leading to
clonal expansion, is linked to a higher risk of cardiovascular mortality and hematologic …

Discovering the drivers of clonal hematopoiesis

O Pich, I Reyes-Salazar, A Gonzalez-Perez… - Nature …, 2022 - nature.com
Mutations in genes that confer a selective advantage to hematopoietic stem cells (HSCs)
drive clonal hematopoiesis (CH). While some CH drivers have been identified, the …